title: Effectiveness of aggressive prophylatic and preemptive therapies targeted against cytomegaloviral and Epstein-Barr viral disease after human intestinal transplantation.
authors.affiliation: Department of Surgery, Dumont-UCLA Transplant Center, Los Angeles, California, USA.
authors.forename: D G
authors.initials: DG
authors.lastname: Farmer
authors.forename: S V
authors.initials: SV
authors.lastname: McDiarmid
authors.forename: D
authors.initials: D
authors.lastname: Winston
authors.forename: H
authors.initials: H
authors.lastname: Yersiz
authors.forename: G
authors.initials: G
authors.lastname: Cortina
authors.forename: S
authors.initials: S
authors.lastname: Dry
authors.forename: A J
authors.initials: AJ
authors.lastname: Maxfield
authors.forename: B
authors.initials: B
authors.lastname: Vandenbogaart
authors.forename: M
authors.initials: M
authors.lastname: Correa
authors.forename: A
authors.initials: A
authors.lastname: Kroeber
authors.forename: S
authors.initials: S
authors.lastname: Geevarghese
authors.forename: R W
authors.initials: RW
authors.lastname: Busuttil
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D020031:Epstein-Barr Virus Infections / Q000517:prevention & control*; D015774:Ganciclovir / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007422:Intestines / Q000637:transplantation*; D012189:Retrospective Studies; D013997:Time Factors; D014184:Transplantation, Homologous
chemical_list: D000998:Antiviral Agents; D015774:Ganciclovir